(Bloomberg) --
Covid-19 is just the beginning for messenger RNA vaccines. Researchers are testing shots across a range of diseases, from cancer to malaria, HIV to multiple sclerosis. While there's no guarantee the technology will work for such afflictions, if it does, it will transform medicine.
©2021 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
